The healthcare sector was a notable outlier early Thursday as markets plummeted on tariff shock. But there are signs of ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

The fear of a trade war over pharmaceuticals between the EU and the US has been avoided for now, but the European Commission ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...

Lastly, Pfizer is a solid dividend stock. It now offers a beefy 6.8% yield, and has increased its payouts by 53.6% in the ...

Pfizer's top-selling product last year was Eliquis, which it co-markets with Bristol Myers Squibb. The blood thinner ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...

The smartest campaigns right now aren’t just throwing out facts and hoping they stick; they’re using sound, emotion and cultural touchpoints to make them stick.

Vaccines are a powerful tool of modern medicine, protecting you from diseases that once caused widespread suffering and death ...

With the recently announced layoffs of 3,500 FDA staffers and exits of branch directors Patrizia Cavazzoni and Peter Marks, ...